104
Participants
Start Date
January 31, 2012
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Control
The control group will receive care from their primary care physician that reflects the actual current care received by KPNC patients, but will not receive any treatment recommendations from the study protocol. The control subject will have regular monitoring of serum uric acid levels and will be provided with educational material and dietary counseling.
Gout Disease Management Program
The experimental group will utilize standard guidelines for the initiation of uric acid lowering treatments, and approved medications. The study protocol treatments include medication management, dietary guidelines, and basic educational materials on gout and its management. No non-formulary medications or devices will be used. The experimental procedure to be tested is the use of a structured protocol to manage and monitor standard treatments.
Kaiser Permanente Northern California Medical Facilities, All KPNC Facilities
Kaiser Permanente
OTHER